Over 12 months, Oscar Health, Inc. saw more selling than buying from its insiders — purchases of about $11.9 million against sales of $150 million.
Bertolini Mark T (CEO) made the biggest buy, worth around $11.9 million. C-suite participation is part of the picture here.
Big money check: 402 institutions held OSCR as of Q2 2026, and more funds bought than sold. Zooming out by quarter: 6 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | WITTMAN VANESSA AMES | Director | Sell | 25,000 | $32.24 | $806K | SEC |
| Sep 8, 2026 | Liang Janet | President | Sell | 10,360 | $31.45 | $326K | SEC |
| Sep 8, 2026 | Baltrus Victoria | Executive Officer | Sell | 958 | $31.45 | $30K | SEC |
| Sep 8, 2026 | Blackley Richard Scott | CFO | Sell | 28,869 | $31.45 | $908K | SEC |
| Sep 8, 2026 | McAnaney Adam | Executive Officer | Sell | 9,092 | $31.45 | $286K | SEC |
| Sep 8, 2026 | Schlosser Mario | Director | Sell | 31,422 | $31.45 | $988K | SEC |
| Aug 31, 2026 | Schlosser Mario | Director | Sell | 600,000 | $30.34 | $18.2M | SEC |
| Aug 31, 2026 | Schlosser Mario | Director | Sell | 150,000 | $30.79 | $4.6M | SEC |
| Aug 20, 2026 | Blackley Richard Scott | CFO | Sell | 18,750 | $31.74 | $595K | SEC |
| Jul 6, 2026 | Schlosser Mario | Director | Sell | 3,600 | $29.50 | $106K | SEC |
| Jul 6, 2026 | Schlosser Mario | Director | Sell | 13,672 | $30.80 | $421K | SEC |
| Jul 6, 2026 | Schlosser Mario | Director | Sell | 30,228 | $31.65 | $957K | SEC |
| Jul 1, 2026 | Bertolini Mark T | CEO | Sell | 488,654 | $28.35 | $13.9M | SEC |
| Jul 1, 2026 | Bertolini Mark T | CEO | Sell | 58,926 | $30.08 | $1.8M | SEC |
| Jul 1, 2026 | Bertolini Mark T | CEO | Sell | 555,826 | $29.17 | $16.2M | SEC |
In the last 12 months Oscar Health, Inc. insiders made open-market purchases worth about $11.9 million and sales worth about $150 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in OSCR was filed on 2026-09-22.
402 investment managers reported holding OSCR in SEC Form 13F filings for Q2 2026.
No congressional trades in OSCR were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).